Metabolic Network Abnormalities in Drug‐Naïve Parkinson's Disease-Reference-Cited by-同舟云学术

Metabolic Network Abnormalities in Drug‐Naïve Parkinson's Disease

Published:2019-12-24 Issue:4 Volume:35 Page:587-594
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Schindlbeck Katharina A.¹,Lucas‐Jiménez Olaia²,Tang Chris C.¹,Morbelli Silvia³⁴,Arnaldi Dario³⁵,Pardini Matteo³⁵,Pagani Marco⁶⁷,Ibarretxe‐Bilbao Naroa²,Ojeda Natalia²,Nobili Flavio³⁵,Eidelberg David¹

Affiliation:

1. Center for Neurosciences The Feinstein Institutes for Medical Research Manhasset New York USA

2. Department of Methods and Experimental Psychology, Faculty of Psychology and Education University of Deusto Bilbao Spain

3. IRCCS Ospedale Policlinico San Martino Genoa Italy

4. Department of Health Science (DISSAL) University of Genoa Genoa Italy

5. Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, and Mother‐Child Health (DINOGMI) University of Genoa Genoa Italy

6. Institute of Cognitive Sciences and Technologies, Consiglio Nazionale delle Ricerche (CNR) Rome Italy

7. Department of Nuclear Medicine Karolinska Hospital Stockholm Sweden

Funder

Deutsche Akademie der Naturforscher Leopoldina - Nationale Akademie der Wissenschaften

National Institute of Neurological Disorders and Stroke

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.27960

Reference39 articles.

1. Current and experimental treatments of Parkinson disease: A guide for neuroscientists

2. NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

3. Advances in markers of prodromal Parkinson disease

4. Building better biomarkers: brain models in translational neuroimaging

5. MDS clinical diagnostic criteria for Parkinson's disease

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers of Parkinson's disease in perspective of early diagnosis and translation of neurotrophic therapies;Basic & Clinical Pharmacology & Toxicology;2024-07-08

2. Deep brain stimulation of the subthalamic nucleus for Parkinson’s disease: A network imaging marker of the treatment response;2024-05-07

3. Functional Brain Networks to Evaluate Treatment Responses in Parkinson's Disease;Neurotherapeutics;2023-10

4. How should we be using biomarkers in trials of disease modification in Parkinson’s disease?;Brain;2023-08-03

5. Differential Implications of Cerebral Hypoperfusion and Hyperperfusion in Parkinson's Disease;Movement Disorders;2023-07-25